Completed NA INTERVENTIONAL 2-arm NCT04812626

Intralesional Triamcinolone Acetonide and Its Combination With 5-fluorouracil in Keloids and Hypertrophic Scars

Efficacy and Safety of Intralesional Triamcinolone Acetonide Alone and Its Combination With 5-fluorouracil in Keloids and Hypertrophic Scars

Sponsor: B.P. Koirala Institute of Health Sciences

Conditions Scar Keloid

Interventions 5-Fluorouracil

Updated 5 times since 2021 Last updated: Mar 30, 2022 Started: Jan 28, 2021 Primary completion: Aug 14, 2021 Completion: Sep 14, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04812626, this NA trial focuses on Scar Keloid and remains completed. Sponsored by B.P. Koirala Institute of Health Sciences, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Apr 2021 — May 2022 [monthly]

Recruiting NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B.P. Koirala Institute of Health Sciences
Nepal Health Research Council

Data source: B.P. Koirala Institute of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dharān, Nepal